Pulse Brain · Growing Health Evidence Index
Peer-reviewed

Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

Roland Seiler, Ewan A. Gibb, Natalie Q. Wang, Htoo Zarni Oo, Hung‐Ming Lam, Kim E. van Kessel, Charlotte S. Voskuilen, Brian Winters, Nicholas Erho, Mandeep Takhar, James J. Douglas, Funda Vakar‐Lopez, Simon J. Crabb, Bas W.G. van Rhijn, Elisabeth E. Fransen van de Putte, Ellen C. Zwarthoff, George N. Thalmann, Elai Davicioni, Joost L. Boormans, Marc Dall’Era, Michiel S. van der Heijden, Jonathan L. Wright, Peter C. Black

Clinical Cancer Research · 2018

Read source ↗ All evidence

Summary

PURPOSE: After cisplatin-based neoadjuvant chemotherapy (NAC), 60% of patients with muscle-invasive bladder cancer (MIBC) still have residual invasive disease at radical cystectomy. The NAC-induced biological alterations in these cisplatin-resistant tumors remain largely unstudied. EXPERIMENTAL DESIGN: Radical cystectomy samples were available for gene expression analysis from 133 patients with residual invasive disease after cisplatin-based NAC, of whom 116 had matched pre-NAC samples. Unsupervised consensus clustering (CC) was performed and the consensus clusters were investigated for their biological and clinical characteristics. Hematoxylin & Eosin and IHC on tissue microarrays were used to confirm tissue sampling and gene expression analysis. RESULTS: Established molecular subtyping m

Subject
Other / interdisciplinary
Source type
Peer-reviewed study
System type
Other
DOI
10.1158/1078-0432.ccr-18-1106
Catalogue ID
BFmommpjky-rj55hc
Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.